hereditary spastic paraplegia 52
hereditary spastic paraplegia 52
Explore linked clinical trials. Standard reference: MONDO:00135522 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system malformation, hereditary disease, hereditary motor and sensory neuropathy, hereditary spastic paraplegia, hereditary spastic paraplegia 11, hereditary spastic paraplegia 15, hereditary spastic paraplegia 3A, hereditary spastic paraplegia 4, hereditary spastic paraplegia 47, hereditary spastic paraplegia 50, hereditary spastic paraplegia 51, hereditary spastic paraplegia 52, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, palsy, paraplegia, peripheral nervous system disorder, polyneuropathy | Recruiting | Not stated | 2026-03-18 | NCT04712812 | |
| Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, central nervous system disorder, central nervous system malformation, hereditary disease, hereditary motor and sensory neuropathy, hereditary spastic paraplegia, hereditary spastic paraplegia 47, hereditary spastic paraplegia 50, hereditary spastic paraplegia 51, hereditary spastic paraplegia 52, inherited neurodegenerative disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy | Not yet recruiting | Phase 1 / Phase 2 | 2025-04-28 | NCT06948019 |